Ibrutinib, sold under the brand name Imbruvica among others, is a small molecule drug that inhibits B-cell proliferation and survival by irreversibly binding the protein Bruton's tyrosine kinase. From Wikipedia
Executives from Merck, Johnson & Johnson, and Bristol Myers Squibb will explain the high cost of their drugs in the U.S. at a Senate hearing.
